Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Aurinia Pharmaceuticals (AUPH)

NASDAQ:AUPH

AUPH

Aurinia Pharmaceuticals

RESEARCH TOOLSreports

Aurinia Pharmaceuticals (AUPH) Financial Statements

Compare

2,093 Followers

Aurinia Pharmaceuticals Financial Overview

Aurinia Pharmaceuticals's market cap is currently $1.66B. The company's EPS TTM is $; its P/E ratio is 29.54; Aurinia Pharmaceuticals is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.